These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10893308)

  • 1. In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.
    Barrow JC; Nantermet PG; Selnick HG; Glass KL; Rittle KE; Gilbert KF; Steele TG; Homnick CF; Freidinger RM; Ransom RW; Kling P; Reiss D; Broten TP; Schorn TW; Chang RS; O'Malley SS; Olah TV; Ellis JD; Barrish A; Kassahun K; Leppert P; Nagarathnam D; Forray C
    J Med Chem; 2000 Jul; 43(14):2703-18. PubMed ID: 10893308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.
    Murali Dhar TG; Nagarathnam D; Marzabadi MR; Lagu B; Wong WC; Chiu G; Tyagarajan S; Miao SW; Zhang F; Sun W; Tian D; Shen Q; Zhang J; Wetzel JM; Forray C; Chang RS; Broten TP; Schorn TW; Chen TB; O'Malley S; Ransom R; Schneck K; Bendesky R; Harrell CM; Vyas KP
    J Med Chem; 1999 Nov; 42(23):4778-93. PubMed ID: 10579841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.
    Nagarathnam D; Miao SW; Lagu B; Chiu G; Fang J; Murali Dhar TG; Zhang J; Tyagarajan S; Marzabadi MR; Zhang F; Wong WC; Sun W; Tian D; Wetzel JM; Forray C; Chang RS; Broten TP; Ransom RW; Schorn TW; Chen TB; O'Malley S; Kling P; Schneck K; Bendesky R; Harrell CM
    J Med Chem; 1999 Nov; 42(23):4764-77. PubMed ID: 10579840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical pharmacology of fiduxosin, a novel alpha(1)-adrenoceptor antagonist with uroselective properties.
    Hancock AA; Buckner SA; Brune ME; Esbenshade TA; Ireland LM; Katwala S; Milicic I; Meyer MD; Kerwin JF; Williams M
    J Pharmacol Exp Ther; 2002 Feb; 300(2):478-86. PubMed ID: 11805207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
    Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
    Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.
    Kuo GH; Prouty C; Murray WV; Pulito V; Jolliffe L; Cheung P; Varga S; Evangelisto M; Wang J
    J Med Chem; 2000 Jun; 43(11):2183-95. PubMed ID: 10841797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of A-131701, a novel, selective antagonist for alpha-1A compared with alpha-1B adrenoceptors on intraurethral and blood pressure responses in conscious dogs and a pharmacodynamic assessment of in vivo prostatic selectivity.
    Hancock AA; Brune ME; Witte DG; Marsh KC; Katwala S; Milicic I; Ireland LM; Crowell D; Meyer MD; Kerwin JF
    J Pharmacol Exp Ther; 1998 May; 285(2):628-42. PubMed ID: 9580607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).
    Chiu G; Li S; Connolly PJ; Pulito V; Liu J; Middleton SA
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3292-7. PubMed ID: 17452102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.
    Nagarathnam D; Wetzel JM; Miao SW; Marzabadi MR; Chiu G; Wong WC; Hong X; Fang J; Forray C; Branchek TA; Heydorn WE; Chang RS; Broten T; Schorn TW; Gluchowski C
    J Med Chem; 1998 Dec; 41(26):5320-33. PubMed ID: 9857099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.
    Lagu B; Tian D; Nagarathnam D; Marzabadi MR; Wong WC; Miao SW; Zhang F; Sun W; Chiu G; Fang J; Forray C; Chang RS; Ransom RW; Chen TB; O'Malley S; Zhang K; Vyas KP; Gluchowski C
    J Med Chem; 1999 Nov; 42(23):4794-803. PubMed ID: 10579842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).
    Chiu G; Li S; Connolly PJ; Pulito V; Liu J; Middleton SA
    Bioorg Med Chem Lett; 2007 Jul; 17(14):3930-4. PubMed ID: 17517507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation of the uroselective properties of four novel alpha(1a)-adrenergic receptor subtype-selective antagonists.
    Pulito VL; Li X; Varga SS; Mulcahy LS; Clark KS; Halbert SA; Reitz AB; Murray WV; Jolliffe LK
    J Pharmacol Exp Ther; 2000 Jul; 294(1):224-9. PubMed ID: 10871316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes.
    Quaglia W; Pigini M; Piergentili A; Giannella M; Gentili F; Marucci G; Carrieri A; Carotti A; Poggesi E; Leonardi A; Melchiorre C
    J Med Chem; 2002 Apr; 45(8):1633-43. PubMed ID: 11931617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.
    Bolognesi ML; Budriesi R; Cavalli A; Chiarini A; Gotti R; Leonardi A; Minarini A; Poggesi E; Recanatini M; Rosini M; Tumiatti V; Melchiorre C
    J Med Chem; 1999 Oct; 42(20):4214-24. PubMed ID: 10514291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.
    Quaglia W; Pigini M; Piergentili A; Giannella M; Marucci G; Poggesi E; Leonardi A; Melchiorre C
    J Med Chem; 1999 Jul; 42(15):2961-8. PubMed ID: 10425105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-Arylpiperazinyl-4-cyclohexylamine derived isoindole-1,3-diones as potent and selective alpha-1a/1d adrenergic receptor ligands.
    Li S; Chiu G; Pulito VL; Liu J; Connolly PJ; Middleton SA
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1646-50. PubMed ID: 17254786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.
    Wong WC; Sun W; Lagu B; Tian D; Marzabadi MR; Zhang F; Nagarathnam D; Miao SW; Wetzel JM; Peng J; Forray C; Chang RS; Chen TB; Ransom R; O'Malley S; Broten TP; Kling P; Vyas KP; Zhang K; Gluchowski C
    J Med Chem; 1999 Nov; 42(23):4804-13. PubMed ID: 10579843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part I.
    Leonardi A; Hieble JP; Guarneri L; Naselsky DP; Poggesi E; Sironi G; Sulpizio AC; Testa R
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1272-83. PubMed ID: 9190863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).
    Chiu G; Li S; Connolly PJ; Pulito V; Liu J; Middleton SA
    Bioorg Med Chem Lett; 2008 Jan; 18(2):640-4. PubMed ID: 18055202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminocyclohexylsulfonamides: discovery of metabolically stable alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).
    Chiu G; Li S; Cai H; Connolly PJ; Peng S; Stauber K; Pulito V; Liu J; Middleton SA
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6123-8. PubMed ID: 17904840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.